Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology. / Molinaro, Antonio; Bel Lassen, Pierre; Henricsson, Marcus; Wu, Hao; Adriouch, Solia; Belda, Eugeni; Chakaroun, Rima; Nielsen, Trine; Bergh, Per-Olof; Rouault, Christine; Andre, Sebastien; Marquet, Florian; Andreelli, Fabrizio; Salem, Joe-Elie; Assmann, Karen; Bastard, Jean-Philippe; Forslund, Sofia; Le Chatelier, Emmanuelle; Falony, Gwen; Pons, Nicolas; Prifti, Edi; Quinquis, Benoit; Roume, Hugo; Vieira-Silva, Sara; Hansen, Tue H.; Pedersen, Helle Krogh; Lewinter, Christian; Sønderskov, Nadja B.; Køber, Lars; Vestergaard, Henrik; Hansen, Torben; Zucker, Jean-Daniel; Galan, Pilar; Dumas, Marc-Emmanuel; Raes, Jeroen; Oppert, Jean-Michel; Letunic, Ivica; Nielsen, Jens; Bork, Peer; Ehrlich, S. Dusko; Stumvoll, Michael; Pedersen, Oluf; Aron-Wisneswky, Judith; Clement, Karine; Baeckhed, Fredrik; MetaCardis Consortium.
In: Nature Communications, Vol. 11, No. 1, 5881, 2020.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
AU - Molinaro, Antonio
AU - Bel Lassen, Pierre
AU - Henricsson, Marcus
AU - Wu, Hao
AU - Adriouch, Solia
AU - Belda, Eugeni
AU - Chakaroun, Rima
AU - Nielsen, Trine
AU - Bergh, Per-Olof
AU - Rouault, Christine
AU - Andre, Sebastien
AU - Marquet, Florian
AU - Andreelli, Fabrizio
AU - Salem, Joe-Elie
AU - Assmann, Karen
AU - Bastard, Jean-Philippe
AU - Forslund, Sofia
AU - Le Chatelier, Emmanuelle
AU - Falony, Gwen
AU - Pons, Nicolas
AU - Prifti, Edi
AU - Quinquis, Benoit
AU - Roume, Hugo
AU - Vieira-Silva, Sara
AU - Hansen, Tue H.
AU - Pedersen, Helle Krogh
AU - Lewinter, Christian
AU - Sønderskov, Nadja B.
AU - Køber, Lars
AU - Vestergaard, Henrik
AU - Hansen, Torben
AU - Zucker, Jean-Daniel
AU - Galan, Pilar
AU - Dumas, Marc-Emmanuel
AU - Raes, Jeroen
AU - Oppert, Jean-Michel
AU - Letunic, Ivica
AU - Nielsen, Jens
AU - Bork, Peer
AU - Ehrlich, S. Dusko
AU - Stumvoll, Michael
AU - Pedersen, Oluf
AU - Aron-Wisneswky, Judith
AU - Clement, Karine
AU - Baeckhed, Fredrik
AU - MetaCardis Consortium
PY - 2020
Y1 - 2020
N2 - Microbiota-host-diet interactions contribute to the development of metabolic diseases. Imidazole propionate is a novel microbially produced metabolite from histidine, which impairs glucose metabolism. Here, we show that subjects with prediabetes and diabetes in the MetaCardis cohort from three European countries have elevated serum imidazole propionate levels. Furthermore, imidazole propionate levels were increased in subjects with low bacterial gene richness and Bacteroides 2 enterotype, which have previously been associated with obesity. The Bacteroides 2 enterotype was also associated with increased abundance of the genes involved in imidazole propionate biosynthesis from dietary histidine. Since patients and controls did not differ in their histidine dietary intake, the elevated levels of imidazole propionate in type 2 diabetes likely reflects altered microbial metabolism of histidine, rather than histidine intake per se. Thus the microbiota may contribute to type 2 diabetes by generating imidazole propionate that can modulate host inflammation and metabolism. Gut microbial metabolism of nutrients contributes to metabolic diseases, and the histidine metabolite imidazole propionate (ImP) is produced by type 2 diabetes (T2D) associated microbiome. Here the authors report that circulating ImP levels are increased in subjects with prediabetes or T2D in three European populations, and this increase associates with altered gut microbiota rather than dietary histidine.
AB - Microbiota-host-diet interactions contribute to the development of metabolic diseases. Imidazole propionate is a novel microbially produced metabolite from histidine, which impairs glucose metabolism. Here, we show that subjects with prediabetes and diabetes in the MetaCardis cohort from three European countries have elevated serum imidazole propionate levels. Furthermore, imidazole propionate levels were increased in subjects with low bacterial gene richness and Bacteroides 2 enterotype, which have previously been associated with obesity. The Bacteroides 2 enterotype was also associated with increased abundance of the genes involved in imidazole propionate biosynthesis from dietary histidine. Since patients and controls did not differ in their histidine dietary intake, the elevated levels of imidazole propionate in type 2 diabetes likely reflects altered microbial metabolism of histidine, rather than histidine intake per se. Thus the microbiota may contribute to type 2 diabetes by generating imidazole propionate that can modulate host inflammation and metabolism. Gut microbial metabolism of nutrients contributes to metabolic diseases, and the histidine metabolite imidazole propionate (ImP) is produced by type 2 diabetes (T2D) associated microbiome. Here the authors report that circulating ImP levels are increased in subjects with prediabetes or T2D in three European populations, and this increase associates with altered gut microbiota rather than dietary histidine.
KW - HOMEOSTASIS MODEL ASSESSMENT
KW - INTESTINAL MICROBIOTA
KW - INSULIN SENSITIVITY
KW - ACCURATE METHOD
KW - GUT MICROBIOME
KW - GLUCOSE
KW - INDIVIDUALS
KW - RISK
KW - METAGENOME
KW - PHYSIOLOGY
U2 - 10.1038/s41467-020-19589-w
DO - 10.1038/s41467-020-19589-w
M3 - Journal article
C2 - 33208748
VL - 11
JO - Nature Communications
JF - Nature Communications
SN - 2041-1723
IS - 1
M1 - 5881
ER -
ID: 253446485